Navigation Links
Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
Date:2/29/2008

KENILWORTH, N.J., Feb. 29 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP) today approved an expanded role and promotion for Ian McInnes, Ph.D., to senior vice president and president, Global Supply Chain. He had been senior vice president, Global Supply Chain. The change reflects the new scope of the company's global supply chain strategy that now includes operations from Organon BioSciences N.V., acquired in November 2007.

McInnes, an adviser to Schering-Plough's Executive Management Team, is responsible for more than 60 manufacturing sites worldwide. His responsibility for Global Supply Chain operations includes the supply of products to Schering-Plough's customers to meet market requirements, as well as the development and implementation of a global manufacturing strategy that integrates all manufacturing facilities worldwide. These include facilities for human prescription medicines and for animal health and consumer health care products. McInnes additionally is responsible for the company's global procurement activities.

McInnes joined Schering-Plough as senior vice president, Global Supply Chain, in May 2004. He holds both a B.S. degree in manufacturing technology and manufacturing management and a Ph.D. degree in manufacturing engineering and systems from the University of Strathclyde in Glasgow, Scotland.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to anima
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Three new locations will be ... wellness centers and one therapeutic dispensary. Patient Appreciation Fair ... weekend of May 25th – May 27th, particularly honoring ... All events will take place from 11:00 ... Elements Therapeutic Dispensary , 10580 S. State Route 69, ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Orriant ... corporate wellness programs to businesses across the U.S. ... been achieved through rigorous infrastructure upgrades for their ... for employee interactions via voice and data. ... lower employee healthcare costs and take ...
(Date:5/17/2013)... 2013 Spring floods, summer droughts and ... gardeners who tend them. Help gardens recover from the ... each year. Myers suggests the following steps to ... Start by assessing the current condition of the landscape. ... harbor insect and disease organisms that can infest healthy ...
(Date:5/17/2013)... 2013 Degenerative changes to the area of ... with compression, known as the nucleus pulposus, has been demonstrated ... new study led by researchers at the Icahn School of ... journal PLOS ONE, reinforces the importance of diabetes in inducing ... is the first study to demonstrate that these changes can ...
(Date:5/17/2013)... Martinson-Nicholls new slip-resistant stair ... slip-resistant renovation tread used on steps that require ... staircase renovation projects, our treads and nosings deliver ... to compliment building designs. Bold Step is strong ... home stairs such as basement or deck steps. ...
Breaking Medicine News(10 mins):Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2
... modeling to bring new understanding to cancer biologyANN ARBOR, Mich., ... world. That,s a fact cancer researchers are beginning to recognize ... in their efforts to understand how cancer develops -- and ... University of Michigan Comprehensive Cancer Center, has come ...
... hypertension, diabetes and blood clots, study says , , FRIDAY, ... during pregnancy are at increased risk for future health ... American and Danish researchers report. , Preeclampsia is a ... The researchers analyzed data on more than 11 million ...
... The California Science Center,s Science Matters speakers program ... Drugs: Good Medicine - Bad Behavior" on Saturday, February 7, ... will provide an overview of the science behind addiction and ... rapid rise of this addiction, questioning whether efforts to curtail ...
... San Diego (UCSD) and the Moores UCSD Cancer Center have ... cancer cells from normal cells. The technique, which is based ... may eventually lead to better ways for surgeons to determine ... cancer surgery and cut down on the number of needed ...
... 30 Some fourth-graders at the Sidney Lanier Center ... more relaxing to enjoy a good book. This after ... in part by a donation from Equal Health. The ... December through http://www.donorschoose.org , a website that lets ...
... HOUSTON, Jan. 30 Access MediQuip, LLC, the nation,s ... management solutions to the health care industry, announced today ... created position of Executive Vice President of Payor Sales ... will lead the company,s strategic initiatives and operations that ...
Cached Medicine News:Health News:Physics, Math Provide Clues to Unraveling Cancer 2Health News:Preeclampsia in Pregnancy Boosts Future Health Risks 2Health News:'Prescription Drugs: Good Medicine - Bad Behavior;' Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center 2Health News:'Prescription Drugs: Good Medicine - Bad Behavior;' Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center 3Health News:Automated screening process may eventually reduce additional breast cancer surgeries 2Health News:Automated screening process may eventually reduce additional breast cancer surgeries 3Health News:Reading in the Comfort of Their Own Classroom 2Health News:Access MediQuip Appoints Executive Vice President of Payor Sales and Services 2
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
(Date:5/16/2013)... -- Nektar Therapeutics, (Nasdaq: NKTR ) President and Chief ... scheduled to present at the upcoming 2013 UBS Global Healthcare ... Sheraton New York Hotel on Tuesday, May 21, 2013 at ... accessible via a Webcast through a link posted in the ... http://www.nektar.com . This Webcast will be available for replay until ...
(Date:5/16/2013)... 2013  Alere Inc. (NYSE: ALR ), a ... health at home through the merger of rapid diagnostics and ... share on its Series B Convertible Perpetual Preferred Stock (NYSE: ... holders of record of Series B stock at the close ... will cover the amount of all dividends accrued from April ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Testosterone is the most important androgen ... is secreted,primarily by the Leydig cells of ... circulating testosterone is derived from,peripheral conversion of ... ca. 25% from the adrenal glands. The ...
Microalbumin Turbidimetric Lipid / Protein Quantification 021-SDX001...
... an enzyme immunometric assay (EIA) in ... phase,incubation, designed for the quantitative measurement ... is coated,with anti-rabbit antibodies.,Calibrators and patient ... wells, along with rabbit anticortisol,antibodies and ...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N...
Medicine Products: